STOCK OPTION AGREEMENT WITH JOSEPH ESPOSITO

This Non-Statutory Option Agreement (the "Agreement") is made and entered into as of August 4, 2008 by and among ADUROMED INDUSTRIES, INC., a Delaware Corporation with a principal of business at 3 Trowbridge Drive, Bethel, Connecticut 06801, of the one part (hereinafter referred to as “AII” or the “Corporation”), and Joseph Esposito,   of the other part   (the "Optionee").

WHEREAS, by action unanimously taken by the Board of Directors of the Corporation on July 31, 2008, the Board approved the 2008 Non-Statutory Stock Option Plan (“Plan”) of the Corporation and authorized the Corporation to provide for the granting of option rights under the Plan to employees, consultants and non-employee directors of the Corporation and the Corporation’s wholly-owned subsidiary, Aduromed Corporation (“Aduromed”), to purchase shares of the Corporation’s common stock, par value $0.0001 per share (“Common Stock”) in connection with the transactions contemplated by that certain Master Restructuring Agreement, dated as of July 10, 2008 by and among the Corporation, Aduromed and the other signatories listed on the signature pages thereto (the “MRA”); and

WHEREAS, in order to facilitate the purpose of the MRA, the Corporation wishes to grant to Optionee the right and option to purchase 12,000,000 shares of Common Stock under the Plan;

NOW , THEREFORE, the parties hereto hereby agree as follows:

1. Grant of Option. The Corporation hereby grants to Optionee and to his permitted designees and assignees, the right and option (“Option”) to purchase a total of 12,000,000 shares of Common Stock (the “Optioned Shares”). It is understood and acknowledged that this Option is designated as a non-statutory stock option that will not qualify as an incentive stock option under Section 422 of the Internal Revenue Code (the “Code”).

2. Option Price. The price to be paid for the Optioned Shares to be issued upon exercise of this Option or any part thereof shall be $0.025 per share (the "Exercise Price").

3. Rights to Exercise.  

The rights to exercise this Option shall vest with respect to 4,000,000 shares of Common Stock immediately, with respect to an additional 4,000,000 shares of Common Stock on August 4, 2009, and with respect to the remaining 4,000,000 shares of Common Stock on August 4, 2010.

4. Securities Law Requirements. To the extent this Option shall have vested as provided in Section 3 above, it may be exercised in whole or in part at any time, subject to an opinion of legal counsel for the Corporation (which shall not be unreasonably withheld by the Corporation) that, at the time of such exercise, the issuance of the Optioned Shares is in compliance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations promulgated there under (the "Securities Act").

5. Term of the Options. The Option shall remain exercisable as to Optioned Shares for five (5) years from the date of vesting of such Optioned Shares.

Should the Optionee’s service be terminated for cause (as defined in the consulting agreement with the Corporation applicable to Optionee), then in any such event this Option shall terminate immediately and with respect to all unvested shares of Common Stock.

In the event Optionee is unable to continue as a consultant as a result of his total and permanent disability (as defined in Section 22(e)(3) of the Code), all of Optionee's unvested Options shall immediately vest and become exercisable and the term of any such Options shall be extended to the fifth anniversary of Optionee's consultancy termination date.

During the term of this Option if the Optionee was at the time of his death still engaged as a consultant, all of the Optionee's unvested Options shall immediately vest and become exercisable and the term of any such Options shall be extended to the fifth anniversary of the Optionee's date of death and the Option may be exercised by the Optionee’s estate or by a person who acquired the right to exercise the Option by bequest or inheritance.

If during the term of this Agreement and while the Optionee remains a consultant of the Corporation, the Corporation shall be subject to a Change in Control, then in such case all of the Optionee's unvested Options shall immediately vest and become exercisable and the term of any such Options shall be extended to the fifth anniversary of the date of Change in Control.

"Change in Control" shall mean any merger, consolidation, sale of assets or other similar transaction or series of transactions involving the Corporation, other than any such transaction or transactions following which the Corporation or its stockholders continue to own a majority of the combined voting power of the outstanding securities of the Corporation or other entity surviving or succeeding to the business of the Corporation.

7. Nontransferability. Except as otherwise provided herein or unless the Corporation otherwise consents in writing, the rights of Optionee hereunder shall be non-assignable and non-transferable by the Optionee, either voluntarily or by opera